Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lönnroth K[au]:

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Getahun H et al. Eur Respir J. (2015)

Multidrug-resistant tuberculosis and migration to Europe. Hargreaves S et al. Clin Microbiol Infect. (2017)

Towards tuberculosis elimination: an action framework for low-incidence countries. Lönnroth K et al. Eur Respir J. (2015)

Search results

Items: 1 to 50 of 142

1.

The Financial Burden of Tuberculosis for Patients in the Western-Pacific Region.

Viney K, Islam T, Hoa NB, Morishita F, Lönnroth K.

Trop Med Infect Dis. 2019 Jun 17;4(2). pii: E94. doi: 10.3390/tropicalmed4020094. Review.

2.

Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews.

Collin SM, Wurie F, Muzyamba MC, de Vries G, Lönnroth K, Migliori GB, Abubakar I, Anderson SR, Zenner D.

Eur Respir Rev. 2019 May 29;28(152). pii: 180107. doi: 10.1183/16000617.0107-2018. Print 2019 Jun 30. Review.

3.

Development and validation of a prediction model for active tuberculosis case finding among HIV-negative/unknown populations.

Shih YJ, Ayles H, Lönnroth K, Claassens M, Lin HH.

Sci Rep. 2019 Apr 16;9(1):6143. doi: 10.1038/s41598-019-42372-x.

4.

Building a European database to gather multi-country evidence on active and latent TB screening for migrants.

Öhd JN, Lönnroth K, Abubakar I, Aldridge RW, Erkens C, Jonsson J, Marchese V, Matteelli A, Menezes D, Zenner D, Hergens MP.

Int J Infect Dis. 2019 Mar;80S:S45-S49. doi: 10.1016/j.ijid.2019.02.041. Epub 2019 Feb 28.

5.

Diagnostic pathways and delay among tuberculosis patients in Stockholm, Sweden: a retrospective observational study.

Wikell A, Åberg H, Shedrawy J, Röhl I, Jonsson J, Berggren I, Buxbaum C, Lönnroth K, Bruchfeld J.

BMC Public Health. 2019 Feb 4;19(1):151. doi: 10.1186/s12889-019-6462-5.

6.

Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks.

Pedrazzoli D, Borghi J, Viney K, Houben RMGJ, Lönnroth K.

Int J Tuberc Lung Dis. 2019 Jan 1;23(1):5-11. doi: 10.5588/ijtld.18.0318.

7.

TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol.

Rachow A, Ivanova O, Wallis R, Charalambous S, Jani I, Bhatt N, Kampmann B, Sutherland J, Ntinginya NE, Evans D, Lönnroth K, Niemann S, Schaible UE, Geldmacher C, Sanne I, Hoelscher M, Churchyard G.

BMC Pulm Med. 2019 Jan 7;19(1):4. doi: 10.1186/s12890-018-0777-3.

8.

Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes.

Collin SM, de Vries G, Lönnroth K, Migliori GB, Abubakar I, Anderson SR, Zenner D.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801449. doi: 10.1183/13993003.01449-2018. Print 2018 Dec.

PMID:
30309977
9.

Measuring catastrophic costs due to tuberculosis in Viet Nam.

Nhung NV, Hoa NB, Anh NT, Anh LTN, Siroka A, Lönnroth K, Garcia Baena I.

Int J Tuberc Lung Dis. 2018 Sep 1;22(9):983-990. doi: 10.5588/ijtld.17.0859.

PMID:
30092862
10.

What value for whom? - provider perspectives on health examinations for asylum seekers in Stockholm, Sweden.

Delilovic S, Kulane A, Åsbring N, Marttila A, Lönnroth K.

BMC Health Serv Res. 2018 Aug 3;18(1):601. doi: 10.1186/s12913-018-3422-1.

11.

Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.

Alene KA, Clements ACA, McBryde ES, Jaramillo E, Lönnroth K, Shaweno D, Gulliver A, Viney K.

J Infect. 2018 Nov;77(5):357-367. doi: 10.1016/j.jinf.2018.07.007. Epub 2018 Jul 20. Review.

PMID:
30036607
12.

Smear Microscopy for Diagnosis of Pulmonary Tuberculosis in Eastern Sudan.

Shuaib YA, Khalil EAG, Schaible UE, Wieler LH, Bakheit MAM, Mohamed-Noor SE, Abdalla MA, Homolka S, Andres S, Hillemann D, Lonnroth K, Richter E, Niemann S, Kranzer K.

Tuberc Res Treat. 2018 Jun 14;2018:8038137. doi: 10.1155/2018/8038137. eCollection 2018.

13.

Defining a migrant-inclusive tuberculosis research agenda to end TB.

Shete PB, Boccia D, Dhavan P, Gebreselassie N, Lönnroth K, Marks S, Matteelli A, Posey DL, van der Werf MJ, Winston CA, Lienhardt C.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):835-843. doi: 10.5588/ijtld.17.0503. Review. Erratum in: Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1244.

14.

Reflections on the State of the Art series on TB and migration, and the way forward.

Shah S, Lange C, Lönnroth K.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):829. doi: 10.5588/ijtld.18.0415. No abstract available.

15.

Modelling the impact of social protection on tuberculosis: the S-PROTECT project.

Boccia D, Rudgard W, Shrestha S, Lönnroth K, Eckhoff P, Golub J, Sanchez M, Maciel E, Rasella D, Shete P, Pedrazzoli D, Houben R, Chang S, Dowdy D.

BMC Public Health. 2018 Jun 26;18(1):786. doi: 10.1186/s12889-018-5539-x.

16.

Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium.

Abubakar I, Matteelli A, de Vries G, Zenner D, Cirillo DM, Lönnroth K, Popescu G, Barcellini L, Story A, Migliori GB.

Eur Respir J. 2018 May 10;51(5). pii: 1702604. doi: 10.1183/13993003.02604-2017. Print 2018 May. No abstract available.

PMID:
29748241
17.

The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of Sustainable Development Goal 1.

Carter DJ, Glaziou P, Lönnroth K, Siroka A, Floyd K, Weil D, Raviglione M, Houben RMGJ, Boccia D.

Lancet Glob Health. 2018 May;6(5):e514-e522. doi: 10.1016/S2214-109X(18)30195-5. Epub 2018 Mar 23.

18.

Uptake of governmental social protection and financial hardship during drug-resistant tuberculosis treatment in Rio de Janeiro, Brazil.

Rudgard WE, das Chagas NS, Gayoso R, Barreto ML, Boccia D, Smeeth L, Rodrigues LC, Lönnroth K, Williamson E, Maciel ELN.

Eur Respir J. 2018 Mar 22;51(3). pii: 1800274. doi: 10.1183/13993003.00274-2018. Print 2018 Mar. No abstract available.

19.

'Valuable but incomplete!' A qualitative study about migrants' perspective on health examinations in Stockholm.

Shedrawy J, Lönnroth K, Kulane A.

Int Health. 2018 May 1;10(3):191-196. doi: 10.1093/inthealth/ihy007.

PMID:
29474639
20.

Sequelae of multidrug-resistant tuberculosis: protocol for a systematic review and meta-analysis.

Alene KA, Clements ACA, McBryde ES, Jaramillo E, Lonnroth K, Shaweno D, Viney K.

BMJ Open. 2018 Feb 10;8(2):e019593. doi: 10.1136/bmjopen-2017-019593.

21.

Tuberculosis, social determinants and co-morbidities (including HIV).

Duarte R, Lönnroth K, Carvalho C, Lima F, Carvalho ACC, Muñoz-Torrico M, Centis R.

Pulmonology. 2018 Mar - Apr;24(2):115-119. doi: 10.1016/j.rppnen.2017.11.003. Epub 2017 Dec 21. Review.

22.

Provider initiated tuberculosis case finding in outpatient departments of health care facilities in Ghana: yield by screening strategy and target group.

Ohene SA, Bonsu F, Hanson-Nortey NN, Toonstra A, Sackey A, Lonnroth K, Uplekar M, Danso S, Mensah G, Afutu F, Klatser P, Bakker M.

BMC Infect Dis. 2017 Dec 1;17(1):739. doi: 10.1186/s12879-017-2843-5.

23.

Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.

Rudgard WE, Evans CA, Sweeney S, Wingfield T, Lönnroth K, Barreira D, Boccia D.

PLoS Med. 2017 Nov 7;14(11):e1002418. doi: 10.1371/journal.pmed.1002418. eCollection 2017 Nov.

24.

Association of Obesity, Diabetes, and Risk of Tuberculosis: Two Population-Based Cohorts.

Lin HH, Wu CY, Wang CH, Fu H, Lönnroth K, Chang YC, Huang YT.

Clin Infect Dis. 2018 Feb 10;66(5):699-705. doi: 10.1093/cid/cix852.

25.

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.

Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T, Lalli M, White RG, Salomon JA, Cohen T, Foster N, Chatterjee S, Sweeney S, Baena IG, Lönnroth K, Weil DE, Vassall A.

Lancet Glob Health. 2017 Nov;5(11):e1123-e1132. doi: 10.1016/S2214-109X(17)30341-8.

26.

Methodological considerations for economic modelling of latent tuberculous infection screening in migrants.

Shedrawy J, Siroka A, Oxlade O, Matteelli A, Lönnroth K.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):977-989. doi: 10.5588/ijtld.17.0134. Review.

PMID:
28826446
27.

Modelling the social and structural determinants of tuberculosis: opportunities and challenges.

Pedrazzoli D, Boccia D, Dodd PJ, Lönnroth K, Dowdy DW, Siroka A, Kimerling ME, White RG, Houben RMGJ.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):957-964. doi: 10.5588/ijtld.16.0906. Review.

28.

Computer-aided reading of tuberculosis chest radiography: moving the research agenda forward to inform policy.

Ahmad Khan F, Pande T, Tessema B, Song R, Benedetti A, Pai M, Lönnroth K, Denkinger CM.

Eur Respir J. 2017 Jul 13;50(1). pii: 1700953. doi: 10.1183/13993003.00953-2017. Print 2017 Jul. No abstract available.

29.

Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease.

Imtiaz S, Shield KD, Roerecke M, Samokhvalov AV, Lönnroth K, Rehm J.

Eur Respir J. 2017 Jul 13;50(1). pii: 1700216. doi: 10.1183/13993003.00216-2017. Print 2017 Jul.

30.

Radiological screening of refugees in Germany.

Herzmann C, Golakov M, Malekzada F, Lonnroth K, Kranzer K.

Eur Respir J. 2017 May 25;49(5). pii: 1602487. doi: 10.1183/13993003.02487-2016. Print 2017 May. No abstract available.

31.

The long and winding road of chest radiography for tuberculosis detection.

Miller C, Lonnroth K, Sotgiu G, Migliori GB.

Eur Respir J. 2017 May 21;49(5). pii: 1700364. doi: 10.1183/13993003.00364-2017. Print 2017 May. No abstract available.

32.

Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.

Lönnroth K, Mor Z, Erkens C, Bruchfeld J, Nathavitharana RR, van der Werf MJ, Lange C.

Int J Tuberc Lung Dis. 2017 Jun 1;21(6):624-637. doi: 10.5588/ijtld.16.0845. Review.

PMID:
28482956
33.

Response to Letter to the Editor by M. van der Werf, V. Hollo and C. Ködmön concerning 'Multidrug-resistant tuberculosis and migration to Europe'.

Hargreaves S, Lönnroth K, Nellums LB, Olaru ID, Nathavitharana RR, Norredam M, Friedland JS.

Clin Microbiol Infect. 2017 Aug;23(8):580. doi: 10.1016/j.cmi.2017.02.022. Epub 2017 Feb 28. No abstract available.

34.

Multidrug-resistant tuberculosis and migration to Europe.

Hargreaves S, Lönnroth K, Nellums LB, Olaru ID, Nathavitharana RR, Norredam M, Friedland JS.

Clin Microbiol Infect. 2017 Mar;23(3):141-146. doi: 10.1016/j.cmi.2016.09.009. Epub 2016 Sep 23. Review.

35.

State-of-the-art series on tuberculosis and migration.

Lönnroth K, Shah NS, Lange C.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1280-1281. No abstract available.

36.

Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities.

Boccia D, Pedrazzoli D, Wingfield T, Jaramillo E, Lönnroth K, Lewis J, Hargreaves J, Evans CA.

BMC Infect Dis. 2016 Jun 21;16:307. doi: 10.1186/s12879-016-1529-8.

37.

Tuberculosis control.

Kranzer K, Khan P, Godfrey-Fausset P, Ayles H, Lönnroth K.

Lancet. 2016 Mar 19;387(10024):1159-60. doi: 10.1016/S0140-6736(16)00710-8. No abstract available.

PMID:
27025331
38.

Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions.

Lienhardt C, Lönnroth K, Menzies D, Balasegaram M, Chakaya J, Cobelens F, Cohn J, Denkinger CM, Evans TG, Källenius G, Kaplan G, Kumar AM, Matthiessen L, Mgone CS, Mizrahi V, Mukadi YD, Nguyen VN, Nordström A, Sizemore CF, Spigelman M, Squire SB, Swaminathan S, Van Helden PD, Zumla A, Weyer K, Weil D, Raviglione M.

PLoS Med. 2016 Mar 2;13(3):e1001965. doi: 10.1371/journal.pmed.1001965. eCollection 2016 Mar. Review. No abstract available.

39.

Addressing diabetes mellitus as part of the strategy for ending TB.

Harries AD, Kumar AM, Satyanarayana S, Lin Y, Zachariah R, Lönnroth K, Kapur A.

Trans R Soc Trop Med Hyg. 2016 Mar;110(3):173-9. doi: 10.1093/trstmh/trv111. Review.

40.

The WHO's new End TB Strategy in the post-2015 era of the Sustainable Development Goals.

Lönnroth K, Raviglione M.

Trans R Soc Trop Med Hyg. 2016 Mar;110(3):148-50. doi: 10.1093/trstmh/trv108. Review.

41.

Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration.

Matteelli A, Lönnroth K, Mosca D, Getahun H, Centis R, D'Ambrosio L, Jaramillo E, Migliori GB, Raviglione MC.

Eur Respir J. 2016 Feb;47(2):686-8. doi: 10.1183/13993003.01597-2015. No abstract available.

42.

Association between spending on social protection and tuberculosis burden: a global analysis.

Siroka A, Ponce NA, Lönnroth K.

Lancet Infect Dis. 2016 Apr;16(4):473-9. doi: 10.1016/S1473-3099(15)00401-6. Epub 2015 Dec 23.

43.

Numbers needed to treat to prevent tuberculosis.

Matteelli A, Lönnroth K, Getahun H, Falzon D, Migliori GB, Raviglione M.

Eur Respir J. 2015 Dec;46(6):1838-9. doi: 10.1183/13993003.01179-2015. No abstract available.

44.

Diabetes and tuberculosis co-epidemic: the Bali Declaration.

Kapur A, Harries AD, Lönnroth K, Wilson P, Sulistyowati LS.

Lancet Diabetes Endocrinol. 2016 Jan;4(1):8-10. doi: 10.1016/S2213-8587(15)00461-1. Epub 2015 Nov 25. No abstract available.

PMID:
26620249
45.

Interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries: a systematic review and meta-analysis.

Weaver MS, Lönnroth K, Howard SC, Roter DL, Lam CG.

Bull World Health Organ. 2015 Oct 1;93(10):700-711B. Epub 2015 Jun 23. Review.

47.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M.

Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24. Review.

48.

Diabetes mellitus and tuberculosis: programmatic management issues.

Harries AD, Kumar AM, Satyanarayana S, Lin Y, Zachariah R, Lönnroth K, Kapur A.

Int J Tuberc Lung Dis. 2015 Aug;19(8):879-86. doi: 10.5588/ijtld.15.0069.

49.

Costs of diagnostic algorithms: whose perspective counts?

Lönnroth K.

Int J Tuberc Lung Dis. 2015 Aug;19(8):878. doi: 10.5588/ijtld.15.0524. No abstract available.

PMID:
26162351
50.

WHO's new end TB strategy.

Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H, Gilpin C, Glaziou P, Grzemska M, Mirzayev F, Nakatani H, Raviglione M; for WHO's Global TB Programme.

Lancet. 2015 May 2;385(9979):1799-1801. doi: 10.1016/S0140-6736(15)60570-0. Epub 2015 Mar 24. No abstract available.

PMID:
25814376

Supplemental Content

Loading ...
Support Center